Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 12:40 AM
NCT ID: NCT06002867
Eligibility Criteria: Inclusion Criteria: * Between the ages of 18-65, * Coronary artery patients with normal left ventricular function and scheduled for elective coronary artery bypass surgery, * Valve diseases for which elective valve replacement is planned with normal left ventricular function, * Cases of ASD (Atrial Septal Defect) for atrial septal defect closure * Patients who will have elective valve + coronary artery bypass without left ventricular dysfunction and patients who volunteer to participate in the study, * No coagulation disorder * Patients with a platelet count of more than 100,000, * Patients with good mental status, * Patients with an ejection difference value (E/F) above 50% will be included in the study. Exclusion Criteria: * Cases that will require emergency and repeat heart surgery, * With advanced left coronary artery disease and left ventricular dysfunction, * Receiving preoperative inotropic support therapy for any reason, * Mitral stenosis with atrial thrombus, * Patients with low cardiac out put syndrome and E/F below 50%, * Patients who need intra-aortic balloon pump during surgery, * Patients with bleeding and coagulation disorders, * Patients with hepatic and renal dysfunction, * Patients with Uncontrolled Diabetes Mellitus and Chronic Obstructive Pulmonary Disease, * Patients allergic to opioids, analgesics and bupivacaine, * Patients with atrial fibrillation using anticoagulants, * Patients with cognitive dysfunction * Patients who do not want to participate in the study will be excluded from the study.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06002867
Study Brief:
Protocol Section: NCT06002867